Homozygote drepanocytosis: Ferric status and inflammation in world and Africa: Review article and meta analysis.
ferritin
hemoglobin
hemolysis
inflammation
serum iron
sickle cell anemia
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
10
05
2023
revised:
15
09
2023
accepted:
19
09
2023
medline:
9
10
2023
pubmed:
9
10
2023
entrez:
9
10
2023
Statut:
epublish
Résumé
Major sickle cell syndromes are subjected to a high frequency of hemolysis, infections, oxidative stress, and vasooclusive crises which promote inflammation and iron balance disorders. We aimed to systematically review and analyze the studies in this patients addressing in general, and Africa in particular. The systematic review of published articles in the Pubmed and Google Scholar databases was carried out according to the recommendations of the PRISMA model. The case-control articles have been included. The data extracted from the articles were analyzed using statistical software R. The standardized mean difference (SMD) was used to assess the extent of the disease on the different variables studied. At the end, 128 articles were obtained; but only 33 were elligible for meta-analysis. A SMD of -1.79 was obtained for hemoglobin between the sickle cell patients and the controls due to the deviation from the overall mean hemoglobin in the cases (8 ± 2 g/dL) and in controls (13 ± 3 g/dL). Sickle cell disease showed a significant extent on ferritin [SMD = 2.61; (95% confidence interval, CI: 2.39-2.83); ( Patients with major sickle cell syndrome in inflammation have a higher risk of iron profile disorders compared to the normal population. Further studies are needed to explore mechanisms for preventing the deleterious effects of iron from this hemolysis, for example haptoglobin genotyping.
Sections du résumé
Background and Aims
UNASSIGNED
Major sickle cell syndromes are subjected to a high frequency of hemolysis, infections, oxidative stress, and vasooclusive crises which promote inflammation and iron balance disorders. We aimed to systematically review and analyze the studies in this patients addressing in general, and Africa in particular.
Methods
UNASSIGNED
The systematic review of published articles in the Pubmed and Google Scholar databases was carried out according to the recommendations of the PRISMA model. The case-control articles have been included. The data extracted from the articles were analyzed using statistical software R. The standardized mean difference (SMD) was used to assess the extent of the disease on the different variables studied.
Results
UNASSIGNED
At the end, 128 articles were obtained; but only 33 were elligible for meta-analysis. A SMD of -1.79 was obtained for hemoglobin between the sickle cell patients and the controls due to the deviation from the overall mean hemoglobin in the cases (8 ± 2 g/dL) and in controls (13 ± 3 g/dL). Sickle cell disease showed a significant extent on ferritin [SMD = 2.61; (95% confidence interval, CI: 2.39-2.83); (
Conclusion
UNASSIGNED
Patients with major sickle cell syndrome in inflammation have a higher risk of iron profile disorders compared to the normal population. Further studies are needed to explore mechanisms for preventing the deleterious effects of iron from this hemolysis, for example haptoglobin genotyping.
Identifiants
pubmed: 37808933
doi: 10.1002/hsr2.1609
pii: HSR21609
pmc: PMC10551275
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e1609Informations de copyright
© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Sci Rep. 2020 Aug 13;10(1):13780
pubmed: 32792581
PLoS One. 2019 Jul 15;14(7):e0218040
pubmed: 31306416
Br J Haematol. 2012 Feb;156(4):433-45
pubmed: 22122125
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029619895111
pubmed: 31942811
Ann Hematol. 2020 May;99(5):947-953
pubmed: 32140892
Dis Markers. 2020 Aug 18;2020:8842362
pubmed: 32884585
Cytokine. 2015 Mar;72(1):43-7
pubmed: 25569375
Br J Haematol. 2010 Mar;148(5):797-804
pubmed: 19995398
PLoS One. 2017 Mar 3;12(3):e0172147
pubmed: 28257476
Eur J Haematol. 2019 Apr;102(4):319-330
pubmed: 30664257
Eur J Haematol. 2010 Jan 1;84(1):72-8
pubmed: 19732137
Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):527-38
pubmed: 20712260
Medicina (Kaunas). 2019 May 21;55(5):
pubmed: 31117252
Br J Haematol. 2020 Jun;189(6):1204-1209
pubmed: 32030737
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31573976
Am J Hematol. 2004 May;76(1):26-32
pubmed: 15114593
EBioMedicine. 2018 Aug;34:158-164
pubmed: 30056060
Nutrients. 2019 Sep 13;11(9):
pubmed: 31540239
Hemoglobin. 2021 Nov;45(6):358-364
pubmed: 33393394
Med Sante Trop. 2016 Jan-Mar;26(1):83-7
pubmed: 26987842
Vie Med Can Fr. 1972 May;1(5):458-67
pubmed: 4643639
J Clin Invest. 2006 Mar;116(3):808-16
pubmed: 16485041
Blood. 2017 Nov 16;130(20):2215-2223
pubmed: 28931524
Paediatr Int Child Health. 2012 Feb;32(1):27-34
pubmed: 22525445
Rev Bras Hematol Hemoter. 2015 Sep-Oct;37(5):329-35
pubmed: 26408368
Sci Rep. 2018 Dec 3;8(1):17527
pubmed: 30510258
Ann Biol Clin (Paris). 2009 Nov-Dec;67(6):607-12
pubmed: 19939763
Pan Afr Med J. 2019 Oct 13;34:85
pubmed: 31934228
Clin Chem. 2000 Oct;46(10):1619-25
pubmed: 11017940
Clin Appl Thromb Hemost. 2017 Nov;23(8):1010-1017
pubmed: 27582023
Nutrients. 2018 Apr 17;10(4):
pubmed: 29673144
J Am Coll Cardiol. 2008 Sep 23;52(13):1049-51
pubmed: 18848136
Br J Haematol. 2006 Jan;132(1):108-13
pubmed: 16371026
Lipids Health Dis. 2019 Dec 20;18(1):225
pubmed: 31861992
Lipids Health Dis. 2017 Apr 11;16(1):74
pubmed: 28399852
Diabetes. 2008 Jun;57(6):1702-6
pubmed: 18332093
Genet Test Mol Biomarkers. 2011 Oct;15(10):709-13
pubmed: 21651321
Res Integr Peer Rev. 2019 Mar 26;4:5
pubmed: 30962953
BMC Hematol. 2019 Feb 08;19:3
pubmed: 30774961
BMC Nephrol. 2016 Nov 17;17(1):178
pubmed: 27855647
Blood Rev. 2019 Sep;37:100580
pubmed: 31128863
Qatar Med J. 2016 Jan 20;2015(2):14
pubmed: 26835411
Pan Afr Med J. 2015 Jun 15;21:124
pubmed: 26327961
Blood. 2013 Feb 21;121(8):1276-84
pubmed: 23264591
Cytokine. 2014 Feb;65(2):217-21
pubmed: 24290434
PLoS One. 2013 Jul 26;8(7):e68929
pubmed: 23922670
Lipids Health Dis. 2010 Aug 27;9:91
pubmed: 20799970